Abstract
Oxidative stress plays an important role in wound healing but data relating oxidative stress to fracture healing are scarce. Nuclear factor erythroid 2-related factor 2 (Nrf2) is the major transcription factor that controls the cellular defence essential to combat oxidative stress by regulating the expression of antioxidative enzymes. This study examined the impact of Nrf2 on fracture healing using a standard closed femoral shaft fracture model in wild-type (WT) and Nrf2-knockout (Nrf2-KO)-mice. Healing was evaluated by histology, real-time RT-PCR, µCT and biomechanical measurements. We showed that Nrf2 expression is activated during fracture healing. Bone healing and remodelling were retarded in the Nrf2-KO compared to the WT-mice. Nrf2-KO-mice developed significantly less callus tissue compared to WT-mice. In addition, biomechanical testing demonstrated lower strength against shear stress in the Nrf2-KO-group compared to WT. The expression of vascular endothelial growth factor (VEGF) and osteocalcin is reduced during fracture healing in Nrf2-KO-mice. Taken together, our results demonstrate that Nrf2 deficiency in mice results in impaired fracture healing suggesting that Nrf2 plays an essential role in bone regeneration. Pharmacological activation of Nrf2 may have therapeutic potential for the enhancement of fracture healing.
Similar content being viewed by others
References
Einhorn TA (1998) The cell and molecular biology of fracture healing. Clin Orthop Relat Res:S7–21
Turgut A, Gokturk E, Kose N, Kacmaz M, Ozturk HS, Seber S, Acar S (1999) Oxidant status increased during fracture healing in rats. Acta Orthop Scand 70:487–490
Yeler H, Tahtabas F, Candan F (2005) Investigation of oxidative stress during fracture healing in the rats. Cell Biochem Funct 23:137–139
Kelpke SS, Reiff D, Prince CW, Thompson JA (2001) Acidic fibroblast growth factor signaling inhibits peroxynitrite-induced death of osteoblasts and osteoblast precursors. J Bone Miner Res 16:1917–1925
Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, Calkins MJ, Jakel RJ, Johnson JA (2005) Nrf2, a multi-organ protector? Faseb J 19:1061–1066
Wruck CJ, Gotz ME, Herdegen T, Varoga D, Brandenburg LO, Pufe T (2008) Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation. Mol Pharmacol 73:1785–1795
Wruck CJ, Claussen M, Fuhrmann G, Romer L, Schulz A, Pufe T, Waetzig V, Peipp M, Herdegen T, Gotz ME (2007) Luteolin protects rat PC12 and C6 cells against MPP + induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway. J Neural Transm Suppl: 57–67
Takahata Y, Takarada T, Iemata M, Yamamoto T, Nakamura Y, Kodama A, Yoneda Y (2009) Functional expression of beta2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells. J Cell Physiol 218:268–275
Park CK, Lee Y, Kim KH, Lee ZH, Joo M, Kim HH (2014) Nrf2 is a novel regulator of bone acquisition. Bone
Chan K, Lu R, Chang JC, Kan YW (1996) NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci USA 93:13943–13948
Bonnarens F, Einhorn TA (1984) Production of a standard closed fracture in laboratory animal bone. J Orthop Res 2:97–101
Brandenburg LO, Kipp M, Lucius R, Pufe T, Wruck CJ (2010) Sulforaphane suppresses LPS-induced inflammation in primary rat microglia. Inflamm Res 59:443–450
Ben Amor IM, Glorieux FH, Rauch F (2011) Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos 2011:540178
Wruck CJ, Fragoulis A, Gurzynski A, Brandenburg LO, Kan YW, Chan K, Hassenpflug J, Freitag-Wolf S, Varoga D, Lippross S, Pufe T (2011) Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann Rheum Dis 70:844–850
Arai M, Shibata Y, Pugdee K, Abiko Y, Ogata Y (2007) Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells. IUBMB Life 59:27–33
Kim KS, Choi HW, Yoon HE, Kim IY (2010) Reactive oxygen species generated by NADPH Oxidase 2 and 4 are required for chondrogenic differentiation. J Biol Chem 285:40294–40302
Morita K, Miyamoto T, Fujita N, Kubota Y, Ito K, Takubo K, Miyamoto K, Ninomiya K, Suzuki T, Iwasaki R, Yagi M, Takaishi H, Toyama Y, Suda T (2007) Reactive oxygen species induce chondrocyte hypertrophy in endochondral ossification. J Exp Med 204:1613–1623
Hinoi E, Fujimori S, Wang L, Hojo H, Uno K, Yoneda Y (2006) Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation. J Biol Chem 281:18015–18024
Hinoi E, Takarada T, Fujimori S, Wang L, Iemata M, Uno K, Yoneda Y (2007) Nuclear factor E2 p45-related factor 2 negatively regulates chondrogenesis. Bone 40:337–344
Maicas N, Ferrandiz ML, Brines R, Ibanez L, Cuadrado A, Koenders MI, Van den Berg WB, Alcaraz MJ (2011) Deficiency of Nrf2 accelerates the effector phase of arthritis and aggravates joint disease. Antioxid Redox Signal 15:889–901
Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G (1998) Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23:187–196
Beck GR, Moran E, Knecht N (2003) Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. Exp Cell Res 288:288–300
Kweider N, Fragoulis A, Rosen C, Pecks U, Rath W, Pufe T, Wruck CJ (2011) Interplay between vascular endothelial growth factor (VEGF) and nuclear factor erythroid 2-related factor-2 (Nrf2): implications for preeclampsia. J Biol Chem 286:42863–42872
Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther KP, Dehio C, Puhl W, Brenner RE (2002) Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30:472–477
Street J, Bao M, deGuzman L, Bunting S, Peale FV, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RAD, Filvaroff EH (2002) Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. P Natl Acad Sci USA 99:9656–9661
Keramaris NC, Calori GM, Nikolaou VS, Schemitsch EH, Giannoudis PV (2008) Fracture vascularity and bone healing: a systematic review of the role of VEGF. Injury 39(Suppl 2):S45–S57
Pufe T, Wildemann B, Petersen W, Mentlein R, Raschke M, Schmidmaier G (2002) Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat. Cell Tissue Res 309:387–392
Weiss S, Zimmermann G, Pufe T, Varoga D, Henle P (2009) The systemic angiogenic response during bone healing. Arch Orthop Trauma Surg 129:989–997
Nazarian A, Entezari V, Vartanians V, Muller R, Snyder BD (2009) An improved method to assess torsional properties of rodent long bones. J Biomech 42:1720–1725
Acknowledgments
We thank S. Echterhagen, C. Jaeschke, M. Nicolau, A. Rüben and L. Shen for their excellent technical assistance. This work has been supported in part by the Christian-Albrecht-University of Kiel and by a Grant from the AO Germany to S.L. This research project was also in part supported by the Excellence Initiative of the German federal and state governments, the START-Program and by the Interdisciplinary Centre for Clinical Research within the faculty of Medicine at the RWTH Aachen University (T9-3; T9-5; T11-3). This work was in part supported by the DFG (PU 214/5-2, 4-2, 3-2).
Human and Animal Rights and Informed Consent
All experiments were in keeping with the local ethics committees guidelines and permission was obtained.
Author information
Authors and Affiliations
Corresponding author
Additional information
Sebastian Lippross, Rainer Beckmann, Thomas Pufe, and Christoph Jan Wruck, have contributed equally to this work.
All authors state that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Lippross, S., Beckmann, R., Streubesand, N. et al. Nrf2 Deficiency Impairs Fracture Healing in Mice. Calcif Tissue Int 95, 349–361 (2014). https://doi.org/10.1007/s00223-014-9900-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-014-9900-5